CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) announces that Chief Executive Officer Will McGuire has issued the following Letter to Stockholders: To My Fellow Stockholders: I’m very proud of the Ra Medical team’s significant progress in implementing engineering enhancements to improve the performance and extend the shelf life of […]
Peripheral/Endo
InspireMD Announces Live Case Broadcast at ISET 2022 Conference Following the Supplement Approval by the FDA Regarding its Pivotal C-Guardians Trial
Live Case will be Broadcasted Today at 11:00am ET TEL AVIV, Israel, Jan. 18, 2022 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for prevention of stroke caused by Carotid Artery Disease (CAD), today announced that a live case demonstration featuring CGuard™ […]
UH Harrington Heart & Vascular Institute Limb Salvage Advisory Council Diverts Patients from Amputation and Improves Outcomes
Findings published in American Heart Association’s Circulation: Cardiovascular Interventions CLEVELAND – Findings from a first-of-its-kind study conducted at University Hospitals (UH) Harrington Heart & Vascular Institute showed a novel system-wide interdisciplinary team assembled to evaluate alternative treatments to major amputation improved outcomes for patients with Critical Limb-Threatening Ischemia (CLTI). […]
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
Complementary technology to orbital atherectomy expands CSI’s vessel prep market opportunity ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today it has made significant progress towards the commercialization of […]
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
2F XO Cross 14 Microcath platform successfully used in challenging peripheral vascular procedures. PARK CITY, Utah, Jan. 11, 2022 /PRNewswire/ — Transit Scientific announced continued multicenter success with the XO Cross® platform. Dr. Jihad Mustapha, interventional cardiologist at Advanced Cardiac & Vascular Center, Grand Rapids, Michigan USA performed procedures using 2F XO Cross 14 Microcaths […]
Upstream Peripheral’s GoBack CTO Catheter Aces its Exam
100-patient study confirms efficiency of Upstream Peripheral’s GoBack Catheter to cross toughest peripheral vascular lesions CAESAREA, Israel & TAMPA, Fla.–(BUSINESS WIRE)–Upstream Peripheral Technologies announced today that its CTO-busting GoBack® Catheter for crossing and reentry was proven very effective for patients undergoing complex revascularizations in lower limb arteries. The findings are […]
Humacyte Announces Presentation of First Preclinical Results of the HAV™ in Coronary Artery Bypass Grafting at Advanced Therapies Week Conference
DURHAM, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the first preclinical results of the use of Humacyte’s Human Acellular Vessel™ (HAV) in coronary artery bypass grafting (CABG) will be presented at […]
Early Evaluation of Transcarotid Artery Revascularization (TCAR) Versus Carotid Endarterectomy (CEA) Cost-Effectiveness
Rosemont, Ill., Dec. 27, 2021 (GLOBE NEWSWIRE) — A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted life years (QALY). The study is published in the December 2021 issue of […]
Philips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath – CavaClear – with Breakthrough Device Designation
December 22, 2021 Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters CavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal It is estimated that in the United States more than one million patients with IVC filters […]
FDA Grants Marketing Authorization for Inferior Vena Cava Filter Removal Device
SILVER SPRING, Md., Dec. 21, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC) filters. The device is designed for patients who have an IVC filter, a small cage-like device inserted into the largest vein in […]



